| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
123,030,000 |
| Market
Cap: |
18.37(B) |
| Last
Volume: |
534,229 |
Avg
Vol: |
722,222 |
| 52
Week Range: |
$143.31 - $211.65 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 824 |
| Guru Rank Value : 0.5 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
21,700 |
98,555 |
124,204 |
268,793 |
| Total Sell Value |
$3,224,546 |
$16,182,261 |
$20,937,886 |
$52,053,725 |
| Total People Sold |
1 |
8 |
9 |
10 |
| Total Sell Transactions |
1 |
13 |
19 |
36 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barrett Peter |
Director |
– • • |
2004-05-27 |
4/A |
B |
$6.00 |
$571,332 |
I/I |
95,222 |
2,331 |
2.25 |
- |
|
| Atlas Venture Associates Vi, L.p. |
10% Owner |
– – • |
2004-05-27 |
4/A |
B |
$6.00 |
$1,335,000 |
D/D |
222,500 |
2,331 |
2.45 |
- |
|
| Westphal Christoph H |
Director |
– • • |
2004-05-27 |
4 |
B |
$6.00 |
$1,875,000 |
I/I |
312,500 |
300,170 |
2.25 |
- |
|
| Clarke John K |
Director |
– • • |
2004-05-27 |
4 |
B |
$0.00 |
$0 |
I/I |
232,500 |
232,500 |
2.17 |
- |
|
| Berriman John E |
Director |
– • • |
2004-05-27 |
4 |
B |
$6.00 |
$1,560,000 |
I/I |
260,000 |
2,475 |
2.25 |
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2004-05-27 |
4 |
B |
$6.00 |
$776,880 |
I/I |
129,480 |
2,475 |
1.5 |
- |
|
| Barrett Peter |
Director |
– • • |
2004-05-27 |
4 |
B |
$6.00 |
$568,398 |
I/I |
94,733 |
2,340 |
2.25 |
- |
|
| Chp Ii Lp |
10% Owner |
– – • |
2004-05-27 |
4 |
B |
$6.00 |
$1,395,000 |
D/D |
232,500 |
232,500 |
2.45 |
- |
|
| Polaris Venture Management Co III Llc |
10% Owner |
– – • |
2004-05-27 |
4 |
OE |
$6.00 |
$1,875,000 |
I/I |
312,500 |
300,170 |
|
- |
|
| Atlas Venture Associates Vi, L.p. |
10% Owner |
– – • |
2004-05-27 |
4 |
B |
$6.00 |
$1,335,000 |
I/I |
222,500 |
133,501 |
1.5 |
- |
|
| Atlas Venture Associates Vi, L.p. |
10% Owner |
– – • |
2004-05-27 |
4 |
B |
$6.00 |
$568,398 |
D/D |
94,733 |
2,340 |
2.45 |
- |
|
| Arch Venture Partners V Llc |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
| Arch Venture Partners V Lp |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
| Bybee Clinton |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
| Nelsen Robert |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
| Crandell Keith |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
| Schimmel Paul |
Director |
– • – |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,315 |
|
- |
|
| Greene Barry E |
COO and TreasurerOfficer |
• – – |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,631 |
|
- |
|
| Abingworth Management Ltd |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
49,495 |
|
- |
|
| Sharp Philip A |
Director |
– • – |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
233,333 |
|
- |
|
| Arch V Entrepreneurs Fund Lp |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
| Arch Venture Fund V Lp |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
222,500 |
|
- |
|
| Lazarus Steven |
10% Owner |
– – • |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
222,500 |
|
- |
|
748 Records found
|
|
Page 30 of 30 |
|
|
2.76 (1.82%) 
